Nova One Advisor
Global Infectious Disease Treatment Market Size, Share, Forecast Report, 2020-...

Global Infectious Disease Treatment Market Size, Share, Forecast Report, 2020-2027

Status: Published Category: Healthcare Insight Code: 2578 Format: PDF / PPT / Excel

Content

Infectious Disease Treatment Market is expected to exhibit significant growth over the forecast period. The market was valued at approximately USD 179.58 Billion in 2018 is projected to register a CAGR of 7.84% over the forecast period.

Infectious diseases are caused due to organisms such as bacteria, viruses, fungi, or parasites. These diseases can be transmitted through insects, animals or by consuming contaminated food or water or by being exposed to the environment that is infected by these organisms.

Factors such as the rising prevalence of infectious diseases and increasing awareness regarding these diseases are expected to drive the market growth. According to an article published by the World Health Organization (WHO), nearly 50,000 people die suffering from infectious diseases every day.

However, stringent government regulations and low awareness regarding the treatment options in underdeveloped countries are expected to hamper the market growth.

Segmentation

The Global Infectious Disease Treatment Market has been segmented into disease type, treatment, end-user, and region.

Based on disease type, the global infectious disease treatment market has been divided into viral diseases, bacterial diseases, fungal diseases, parasitic diseases, and others.

The global infectious disease treatment market, by treatment, has been segmented into antibiotics, antivirals, antifungals, anti-parasitic, and others.

The global infectious disease treatment market, by end-user, has been segmented into hospitals & clinics, ambulatory care centers, and others.
Key Players

Hoffmann-La Roche Ltd (Switzerland), Pfizer Inc. (US), Janssen Global Services, LLC (US), Sanofi (France), GlaxoSmithKline PLC (UK), Novartis AG (Switzerland), Bristol-Myers Squibb Company (US), Bayer AG (Germany), Eli Lilly and Company (US), Astellas Pharma Inc. (Japan), Merck & Co., Inc. (US), Aurobindo Pharma (India), Dr. Reddy's Laboratories (India), Cipla Inc. (India), Alkem Labs (India), AbbVie Inc. (US) are some of the key players operating in the global infectious disease treatment market.

Global Infectious Disease Treatment Market, by Disease Type

  • Viral Diseases
  • Bacterial Diseases
  • Fungal Diseases
  • Parasitic Diseases
  • Others

Global Infectious Disease Treatment Market, by Treatment

  • Antibiotics
  • Antivirals
  • Antifungals
  • Anti-Parasitic
  • Others

Global Infectious Disease Treatment Market, by End User

  • Hospitals and Clinics
  • Ambulatory Care Centers
  • Others
  • Insight Code: 2578
  • No. of Pages: 250
  • Format: PDF/PPT/Excel
  • Published: July 2020
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034